中国食品药品监管2024,Issue(9) :40-45.DOI:10.3969/j.issn.1673-5390.2024.09.005

浅析金属类骨科植入性医疗器械替代物留样的风险控制

Analysis of Metal Orthopedic Implantable Medical Devices:Risk Control of Surrogate Retention Samples

邓昀 李永红 王文睿 高亚龙
中国食品药品监管2024,Issue(9) :40-45.DOI:10.3969/j.issn.1673-5390.2024.09.005

浅析金属类骨科植入性医疗器械替代物留样的风险控制

Analysis of Metal Orthopedic Implantable Medical Devices:Risk Control of Surrogate Retention Samples

邓昀 1李永红 1王文睿 1高亚龙1
扫码查看

作者信息

  • 1. 甘肃省药品监督管理局审核查验中心(甘肃省疫苗检查中心)
  • 折叠

摘要

在植入性医疗器械的质量管理中,产品留样是上市后监管的重要质量追溯措施,是基于该类产品的特性提出的,符合产品上市后质量持续监测的要求.本文基于《医疗器械监督管理条例》《医疗器械生产监督管理办法》等法规文件要求,分析了金属类骨科植入性医疗器械产品替代物留样的可能性风险,并探索性地提出控制措施,旨在为相关企业开展替代物留样提供参考.

Abstract

In the quality management of implantable medical devices,product retention samples are an important measure for post-market quality traceability,aligning with the requirement for continuous quality monitoring of such products.This paper analyzes the risks associated with surrogate retention samples of metal orthopedic implantable medical devices,based on the legal requirements set forth in regulations such as the Regulations on the Supervision and Administration of Medical Devices and the Measures for the Supervision of Medical Device Production.It also explores potential control measures to provide a reference for enterprises to conduct surrogate sample retention.

关键词

骨科植入物/风险控制/留样替代/质量追溯/不良事件监测

Key words

orthopedic implants/risk control/retention replacement/quality traceability/adverse event monitoring

引用本文复制引用

基金项目

2023年中国药品监督管理研究会课题(2023-Y-Q-007)

出版年

2024
中国食品药品监管
中国医药报社

中国食品药品监管

影响因子:0.099
ISSN:1673-5390
参考文献量4
段落导航相关论文